Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 2928 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Search Again
 Table of Contents
 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Article Access Statistics
 Reader Comments
 Email Alert
 Add to My List
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded68    
    Comments [Add]    

Recommend this journal

Year : 2003  |  Volume : 45  |  Issue : 4  |  Page : 205-207

Is oestrogen a 'Biological Neuroleptic'?

B-166, IIT Kharagpur, Kharagpur- 721 302, West Bengal, India

Correspondence Address:
Subhagata Chattopadyay
B-166, IIT Kharagpur, Kharagpur- 721 302, West Bengal
Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 21206859

Rights and PermissionsRights and Permissions

Objective : Oestrogen-hypothesis in schizophrenia is a largely debated issue. Being a multifactor disorder, schizophrenia has gained importance in the field of psychiatric research, especially to dig out the tentative aetiologies (genetic, biological, environmental etc.), still under tested or not tested. The present article is an attempt only to understand the possible role of oestrogen as a 'core' biological factor at the backdrop of male-female differences (in the onset, course, treatment response, prognosis) in schizophrenia barring other factors. This is to reduce the level of 'conflict' and 'confusion' in the article. Method : Electronic data search is the mainstay of the literature bank, included in the article and only 'supportive' evidences (direct and indirect) are incorporated to understand the role of oestrogen in the brain at the backdrop of schizophrenia. Result: The study comes out with a postulation that oestrogen has got a potential effect in moderating the process of schizophrenia in the females. Conclusion : Oestrogen could be tested as the 'novel' therapeutic agent in the female schizophrenics with the necessary support from the modern Nuclear Imaging Techniques to get maximum therapeutic benefit in schizophrenia.



Print this article         Email this article